Literature DB >> 3055457

An ELISA test for detecting chloroquine in urine.

F C Shenton1, M Bots, A Menon, T A Eggelte, M de Wit, B M Greenwood.   

Abstract

Two ELISA tests for detecting chloroquine in urine have been developed using polyclonal and monoclonal antibodies which react with the 7-chloro-4-amino-quinoline part of the chloroquine molecule and thus recognize chloroquine, its metabolites, and amodiaquine. The ELISAs were sensitive and specific and did not cross-react with other commonly used antimalarials. In a field trial the chloroquine ELISA performed better than the Dill Glazko or Haskins colorimetric tests. A small proportion of urines gave an apparently false positive reaction when tested at a dilution of 1:10, but not when tested at higher dilution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055457     DOI: 10.1016/0035-9203(88)90415-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

1.  The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria.

Authors:  P A Winstanley; W M Watkins; C R Newton; C Nevill; E Mberu; P A Warn; C M Waruiru; I N Mwangi; D A Warrell; K Marsh
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

2.  Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya.

Authors:  M Keuter; A van Eijk; M Hoogstrate; M Raasveld; M van de Ree; W A Ngwawe; W M Watkins; J B Were; A D Brandling-Bennett
Journal:  BMJ       Date:  1990-09-08

3.  Decreased antitoxic activities among children with clinical episodes of malaria.

Authors:  P H Jakobsen; V McKay; R N'Jie; B O Olaleye; U D'Alessandro; G H Zhang; T A Eggelte; C Koch; B M Greenwood
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria.

Authors:  P A Peeters; K de Leest; W M Eling; D J Crommelin
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

5.  Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations.

Authors:  Insaf F Khalil; Michael Alifrangis; Camilla Recke; Lotte C Hoegberg; Anita Ronn; Ib C Bygbjerg; Claus Koch
Journal:  Malar J       Date:  2011-08-24       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.